Literature DB >> 32195140

Introducing new and effective catalysts for the synthesis of pyridazino[1,2-a]indazole, indazolo[2,1-b]phthalazine and pyrazolo[1,2-b]phthalazine derivatives.

Najmeh Amirmahani1,2, Nosrat O Mahmoodi3, Mohammad Malakootian2, Abbas Pardakhty4.   

Abstract

In this study, a new and effective catalyst for the synthesis of pyridazino[1,2-a]indazole, indazolo[2,1-b]phthalazine and pyrazolo[1,2-b]phthalazine derivatives was introduced. Triethanolammonium acetate ([TEAH][OAc]) accelerates the reaction in a one-pot and four-component condensation of aldehydes, hydrazine hydrate, succinic/phthalic anhydride, and 1,3-dicarbonyl compounds. The yield of the products is high, and the reaction conditions are mild and solvent-free. Furthermore, the model reaction was conducted in the presence of triethanolammonium sulphate ([TEAH][HSO4] and triethanolammonium formate ([TEAH][HCOO]) under various conditions. In addition, the catalyst is recyclable, therefore, it can be reused several times. The structure of the obtained products was confirmed by comparing the M.P., IR, and 1H NMR. Advantages of this technique are as following:•Synthesis of novel, green, and one-pot and four-component condensation (4CC) under solvent-free conditions at room temperature.•The catalytic reaction is performed under mild and environmentally friendly conditions in short reaction times and excellent yields.•The catalyst is easily recycled and exhibits good chemical and structural stability.
© 2020 The Author(s).

Entities:  

Keywords:  Catalyst; Four-component condensation reaction; Indazolo[2,1-b]phthalazine; Pyrazolo[1,2-b]phthalazine; Pyridazino[1,2-a]indazole; Synthesis; Triethanolammonium acetate ([TEAH][OAc])

Year:  2020        PMID: 32195140      PMCID: PMC7078373          DOI: 10.1016/j.mex.2020.100823

Source DB:  PubMed          Journal:  MethodsX        ISSN: 2215-0161


Specification table

Methods

Despite recent advances in molecular biology and synthetic combinatorial methodology, the rate of introduction of new drugs has significantly declined over the past two decades. It is believed that making diversity in a potential therapeutic complex increases the rate of success. Most of the drugs that are still in use, are synthetic small organic molecules, often containing a heterocyclic ring. However, a range of easily accessible heterocyclic structures with functional groups suitable for the synthesis of diverse structures in the laboratory is limited. Therefore, the development of new, rapid, and accurate synthetic pathways for these heterocyclic compounds in the laboratory has been very important for the pharmaceutical and synthetic chemists. Undoubtedly, the most efficient tool involves multicomponent reactions (MCRs), which is a powerful tool for the rapid production of diverse compounds [1]. As a result, the design and development of MCRs have received much attention. Multicomponent reactions are a specific type of synthetic useful organic reactions, in which three or more raw materials react to produce the final product in a one-pot method. MCRs are a powerful tool for discovering new drugs, enabling the rapid and automatic production of high-efficiency organic compounds. In addition, the discovery of new MCRs can be considered as an interesting subject for academic research [2]. The development of MCRs in heterocyclic synthesis has attracted the attention of many chemists to synthesize pharmacological compounds. One of the widespread applications of these reactions is the synthesis of indazoles and pyrazoles derivatives. Indazoles and pyrazoles derivatives exhibit a wide range of biological and pharmacological activities, such as the inhibition of protein kinase C-β [3], 5-HT2 and 5-HT3 receptor antagonisms [4], ability to bind to estrogen receptor [5], and HIV virus inhibition [6]. In organic chemistry, there are various uses of solvents. These solvents affect the living organisms because of their toxic nature, which is highly permeable to the environment. To avoid the use of such toxic solvents, the reactions can be carried out using catalysts such as ionic liquids or biological catalysts, which do not harm the environment [7,8]. With increasing the community awareness about recyclable compounds, bio-based and environmentally friendly products have taken a higher priority. Conventional catalysts, such as H2SO4 and HCl, which are acidic catalysts, or alkaline catalysts, such as NaOH, can be replaced by bio-friendly and environmentally friendly catalysts, such as ionic liquids, which act as both acidic and alkaline catalysts. The main goal of green chemistry is to achieve higher efficiency with lower waste and avoid the use of toxic solvents [9,10]. In recent years, ionic liquids have become strong organic solvents because of their special properties, such as ease of product recovery and catalyst recycling [[12], [13], [14], [15], [16], [11]]. Following on from our previous work [17], the present study focused on an easy and green way to synthesize 2H-pyridazino[1,2-a]indazole-1,6,9(11H)-triones, 2H-indazolo[2,1-b]phthalazine-1,6,11(13H)-triones, and 1H-pyrazolo[1,2-b]phthalazine-2-carboxylate derivatives under solvent-free conditions. For this purpose, ([TEAH][OAc]) was used as an ionic liquid catalyst to promote the reaction (Scheme 1). Then, in the other efforts ([TEAH][HSO4] and ([TEAH][HCOO]) were used as ionic liquid catalysts to promote the model reaction (Table 1).
Scheme 1

[TEAH][OAc] catalyzed the synthesis of 6a-7k products.

Table 1

Determination of optimal reaction conditionsa.

Image, table 1
EntryCatalyst (mmol)ConditionsTimeYieldb (%)
1Solvent-Free (100 °C)24 (h)0
2[TEAH][OAc] (0.05 mmol)Solvent-Free (r.t.)24 (h)10
3[TEAH][OAc] (0.05 mmol)Solvent-Free (50 °C)24 (h)25
4[TEAH][OAc] (0.05 mmol)Solvent-Free (80 °C)12 (h)20
5[TEAH][OAc] (0.10 mmol)Solvent-Free (50 °C)5 (h)30
6[TEAH][OAc] (0.10 mmol)Solvent-Free (80 °C)4 (h)40
7[TEAH][OAc] (0.10 mmol)Solvent-Free (100 °C)3 (h)40
8[TEAH][OAc] (0.20 mmol)Solvent-Free (30 °C)1 (h)40
9[TEAH][OAc] (0.20 mmol)Solvent-Free (50 °C)40 (min)80
10[TEAH][OAc] (0.20 mmol)Solvent-Free (80 °C)20 (min)91
11[TEAH][OAc] (0.20 mmol)Solvent-Free (100 °C)20 (min)91
12[TEAH][OAc] (0.25 mmol)Solvent-Free (80 °C)20 (min)91
14[TEAH][OAc] (0.15 mmol)EtOH (80 °C)100 (min)20
15[TEAH][OAc] (0.15 mmol)EtOH/H2O (80 °C)120 (min)25
16[TEAH][OAc] (0.15 mmol)H2O (80 °C)175 (min)20
17[TEAH][OAc] (0.15 mmol)THF (80 °C)220 (min)Trace
18[TEAH][HSO4] (0.10 mmol)Solvent-Free (70 °C)70 (min)52
19[TEAH][HSO4] (0.20 mmol)Solvent-Free (80 °C)70 (min)69
20[TEAH][HSO4] (0.25 mmol)Solvent-Free (80 °C)75 (min)70
21[TEAH][HSO4] (0.20 mmol)Solvent-Free (90 °C)70 (min)75
22[TEAH][HSO4] (0.20 mmol)Solvent-Free (100 °C)70 (min)75
23[TEAH][HCOO] (0.10 mmol)Solvent-Free (70 °C)65 (min)60
24[TEAH][HCOO] (0.20 mmol)Solvent-Free (80 °C)55 (min)78
25[TEAH][HCOO] (0.25 mmol)Solvent-Free (80 °C)55 (min)79
26[TEAH][HCOO] (0.20 mmol)Solvent-Free (90 °C)55 (min)78
27[TEAH][HCOO] (0.20 mmol)Solvent-Free (100 °C)55 (min)78

Reaction conditions: 1 (1 mmol), 2 (benzaldehyde, 1 mmol), 3(1.1 mmol) and 4(1 mmol).

Yields refer to pure isolated yields.

[TEAH][OAc] catalyzed the synthesis of 6a-7k products. Determination of optimal reaction conditionsa. Reaction conditions: 1 (1 mmol), 2 (benzaldehyde, 1 mmol), 3(1.1 mmol) and 4(1 mmol). Yields refer to pure isolated yields.

Experimental design, materials, and methods

Initially, the production of 6a was considered as the model reaction, and formerly, changes of solvent, temperature, and catalyst content were investigated. The indazoles and pyrazoles derivatives were prepared by the one-pot and four-component condensation (4CC). It was focused on a one-pot, 4CC of aldehydes, hydrazine hydrate, succinic/phthalic anhydride, and 1,3-dicarbonyl compounds in the absence or presence of different catalysts under various conditions, and the results are listed in Table 1. In the absence of any catalysts, the model reaction did not proceed successfully and no corresponding product was prepared (Table 1, entry 1). The model reaction was conducted in the presence of [TEAH][OAc] under various conditions (Table 1, entries 1–17) and the best results was obtained in the presence of 20 mol% [TEAH][OAc] under solvent-free condition at 80 °C (Table 1, entry 10). Furthermore, in the presence of ionic liquid [TEAH][HSO4], the desired product was obtained in 52–75% yield (Table 1, entries 18–22) and in the presence of ionic liquid [TEAH][HCOO], the desired product was obtained in 60–79% yield (Table 1, entries 23–27). In the presence of ionic liquid catalyst [TEAH][OAc] the desired products with high efficiency and purity was obtained under solvent-free conditions. The structures of the products were confirmed by M.P., IR, 1H NMR data and comparison with those of authentic samples that obtained earlier. All the samples synthesized under optimal conditions are listed in Table 2.
Table 2

Products synthesized by [TEAH][OAc] catalyst under optimal conditionsa.

EntryR1R21,3-DicarbonylProductTime (min)Yieldb,c (%)
1pHDimedone6a2091 [18]
24-ClC6H4Dimedone6b1892 [18]
34-O2NC6H4Dimedone6c1588 [18]
43-O2NC6H4Dimedone6d1882 [18]
54-CH3OC6H4Dimedone6e3090 [18]
64-CH3C6H4Dimedone6f2570 [18]
72,4-(Cl)2—C6H3Dimedone6g2093 [18]
84-(CH3)2NC6H4Dimedone6h2088 [18]
94-BrC6H4Dimedone6i2279 [18]
104-HOC6H4Dimedone6j3080 [18]
11(CH3)2CHCH2Dimedone6k4057 This Work
12CH3CH2CH2Dimedone6l3550 This Work
13pHDimedone6m1391 [19]
144-ClC6H4Dimedone6n1290 [19]
154-O2NC6H4Dimedone6o1089 [19]
163-O2NC6H4Dimedone6p1395 [19]
174-CH3OC6H4Dimedone6q2092 [19]
184- CH3C6H4Dimedone6r3592 [19]
194-HOC6H4Dimedone6s2091 [19]
20PhCHOEtEthyl 3-oxobutanoate7a3782 [19]
212-ClC6H4EtEthyl 3-oxobutanoate7b3289 [20]
224-BrC6H4EtEthyl 3-oxobutanoate7c3592 [20]
234-NO2C6H4EtEthyl 3-oxobutanoate7d2295 [20]
242,4-Cl, Cl C6H4EtEthyl 3-oxobutanoate7e3087 [20]
254-OCH3C6H4EtEthyl 3-oxobutanoate7f3578 [20]
264-CH3C6H4EtEthyl 3-oxobutanoate7g3575 [20]
274-OHC6H4EtEthyl 3-oxobutanoate7h2880 [20]
284-N(CH3)2C6H4EtEthyl 3-oxobutanoate7i3678 [20]
29pHEtmethyl 3-oxobutanoate7j3585 [20]
304-ClC6H4Etmethyl 3-oxobutanoate7k3087 [20]

Reaction conditions: 1 (1 mmol), 2 (1 mmol), 3 (1.1 mmol), 4 or 5 (1 mmol) and [(CH2CH2OH)3NH][CH3COO] (0.20 m mol) (Scheme 1) solvent-free, 80 °C.

Yields refer to pure isolated yields.

Reference numbers for known compounds.

Products synthesized by [TEAH][OAc] catalyst under optimal conditionsa. Reaction conditions: 1 (1 mmol), 2 (1 mmol), 3 (1.1 mmol), 4 or 5 (1 mmol) and [(CH2CH2OH)3NH][CH3COO] (0.20 m mol) (Scheme 1) solvent-free, 80 °C. Yields refer to pure isolated yields. Reference numbers for known compounds.

Stability and recycling of the catalyst

To promote green synthesis in organic chemistry, the catalyst stability and its reuse were investigated. For this purpose, after the completion of the reaction, the catalyst was separated. The aqueous layer containing the catalyst was separated and extracted under reduced pressure of evaporated water. The obtained ionic liquid was reused in the model reaction. The results showed that the [TEAH][OAc] catalyst was reusable up to the fourth time without a significant decrease in the activity. On the other hand, during four stages of the reaction efficiency recovery, the model was 91% in the first stage and 86% in the fourth stage, indicating that the catalytic activity did not decrease significantly. The proposed mechanism for the synthesis of 6a-7k derivatives by the [TEAH][OAc] catalyst is shown in Scheme 2.
Scheme 2

The proposed mechanism for the synthesis of 6a using [TEAH][OAc].

The proposed mechanism for the synthesis of 6a using [TEAH][OAc]. Firstly, it was assumed that the reaction is conducted via a Knoevenagel condensation between 1,3-dicarbonyl compound 1 and aromatic aldehyde 2 to form the intermediate 7 via intermediate 6 in the presence of [TEAH][OAc], that undergoes immediate Michael addition via CC bond of 7. During the reaction process, the hydrogen ion is transferred from the [TEAH][OAc] to intermediate 8. The concerted cyclocondensation of the amine and carbonyl of the Michael lead to the corresponding product 8 (Scheme 2).

Conclusion

In this research, new, green, and effective catalysts for the synthesis of pyridazino[1,2-a]indazole, indazolo[2,1-b]phthalazine, and pyrazolo[1,2-b]phthalazine derivatives by one-pot 4CC were used. These catalysts have advantages, such as reduced reaction time, high product efficiency, ease of use, and recycling (Fig. 1).
Fig. 1

Recyclability of the catalyst in the model reaction under optimal reaction conditions.

Recyclability of the catalyst in the model reaction under optimal reaction conditions.

Declaration of Competing Interest

The Authors confirm that there are no conflicts of interest.

Specification table

Subject Area:Chemistry
More specific subject area:Organic Chemistry
Method name:Ionic liquid as a catalyst for the synthesis of heterocyclic compounds
Name and reference of original method:Direct submission
Resource availability:Direct submission
  5 in total

1.  Design, synthesis and structure activity relationships of indazole and indole derivatives as potent glucagon receptor antagonists.

Authors:  Fengbin Song; Guozhang Xu; Michael D Gaul; Baoping Zhao; Tianbao Lu; Rui Zhang; Renee L DesJarlais; Karen DiLoreto; Norman Huebert; Brian Shook; Dennis Rentzeperis; Rosie Santulli; Annette Eckardt; Keith Demarest
Journal:  Bioorg Med Chem Lett       Date:  2019-05-18       Impact factor: 2.823

2.  1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity.

Authors:  Jesse A May; Anura P Dantanarayana; Paul W Zinke; Marsha A McLaughlin; Najam A Sharif
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

3.  The discovery of novel 3-aryl-indazole derivatives as peripherally restricted pan-Trk inhibitors for the treatment of pain.

Authors:  Hiromitsu Shirahashi; Eisuke Toriihara; Yoshihito Suenaga; Hideyuki Yoshida; Kensuke Akaogi; Yukiko Endou; Makoto Wakabayashi; Misato Takashima
Journal:  Bioorg Med Chem Lett       Date:  2019-06-17       Impact factor: 2.823

4.  Novel 1,5-diphenylpyrazole nonnucleoside HIV-1 reverse transcriptase inhibitors with enhanced activity versus the delavirdine-resistant P236L mutant: lead identification and SAR of 3- and 4-substituted derivatives.

Authors:  M J Genin; C Biles; B J Keiser; S M Poppe; S M Swaney; W G Tarpley; Y Yagi; D L Romero
Journal:  J Med Chem       Date:  2000-03-09       Impact factor: 7.446

Review 5.  Evolution of green chemistry and its multidimensional impacts: A review.

Authors:  Bianca Aparecida de Marco; Bárbara Saú Rechelo; Eliane Gandolpho Tótoli; Ana Carolina Kogawa; Hérida Regina Nunes Salgado
Journal:  Saudi Pharm J       Date:  2018-07-20       Impact factor: 4.330

  5 in total
  1 in total

1.  [TBP]2SO4 ionic liquid catalyst for 4MCR of pyridazinoindazole, indazolophthalazine and pyrazolophthalazine derivatives.

Authors:  Najmeh Amirmahani; Nosrat O Mahmoodi; Mohammad Malakootian; Abbas Pardakhty
Journal:  Mol Divers       Date:  2020-11-05       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.